How is mesothelioma treated?

Until recently, treatment for mesothelioma has been limited

 

Graphic showing that in the past 15 years, treatment for mesothelioma has been limited. In 2019, the FDA approved a treatment for mesothelioma called NovoTTF-100L™ System
 
The following may help you understand some of the language above:

Unresectable means that a tumor is not able to be removed with surgery.

Locally advanced means that tumors have spread into nearby tissues, organs, or lymph nodes around the cancer’s original site.

Metastatic means the cancer has spread from the point of origination to other tissues and organs in the body.

*FDA approved under the Humanitarian Device Exemption pathway.

References: 1. NovoTTF-100L Instructions For Use for Unresectable Malignant Pleural Mesothelioma. Novocure 2019. 2. FDA Approves the NovoTTF-100L™ System in Combination with Chemotherapy for the Treatment of Malignant Pleural Mesothelioma [press release]. St. Helier, Jersey: Business Wire; May 23, 2019. 3. NovoTTF-100L Patient Information and Prescribing Manual. Novocure 2019. 4. Hazarika M, White RM, Johnson JR, et al. FDA drug approval summaries: pemetrexed (Alimta®). The Oncologist. 2004;9(5):482-488. 5. Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol. 2003;21(14):2636-2644. 6. NCI Dictionary of Cancer Terms. NIH: National Cancer Institute Website. https://www.cancer.gov/publications/dictionaries/cancer-terms. Accessed August 26, 2019.

Next: NovoTTF-100L treatment plan
Back to top
What is the NovoTTF-100L™ System approved to treat?
jump to isi

The NovoTTF-100L System is a wearable, portable, FDA-approved device indicated for…